1. Home
  2. GAIN vs CERS Comparison

GAIN vs CERS Comparison

Compare GAIN & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Investment Corporation Business Development Company

GAIN

Gladstone Investment Corporation Business Development Company

HOLD

Current Price

$16.45

Market Cap

651.5M

Sector

Finance

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.73

Market Cap

585.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIN
CERS
Founded
2005
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
651.5M
585.1M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
GAIN
CERS
Price
$16.45
$2.73
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$14.75
N/A
AVG Volume (30 Days)
194.7K
3.0M
Earning Date
05-12-2026
04-30-2026
Dividend Yield
9.19%
N/A
EPS Growth
20.63
27.27
EPS
0.76
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
$9.07
$19.95
Revenue Next Year
$7.32
$8.84
P/E Ratio
$21.72
N/A
Revenue Growth
N/A
30.68
52 Week Low
$13.14
$1.17
52 Week High
$17.14
$3.47

Technical Indicators

Market Signals
Indicator
GAIN
CERS
Relative Strength Index (RSI) 54.42 48.23
Support Level $15.78 $2.37
Resistance Level $17.01 $2.91
Average True Range (ATR) 0.33 0.15
MACD -0.02 0.02
Stochastic Oscillator 44.57 57.23

Price Performance

Historical Comparison
GAIN
CERS

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S., to achieve and grow current income by investing in debt securities of established businesses, and to provide stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Share on Social Networks: